CLASS II Device recall · Reported 27 Nov 2019 · FDA Enforcement Report

Randox Liquid Cardiac Controls recalled by Randox Laboratories

Randox Laboratories is recalling Randox Liquid Cardiac Controls, distributed in 10 states. The recall was initiated on 4 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalogue Number: CQ5052 GTIN: 05055273207453 Batch/lot: 4244CK (Exp. 28Nov2019), 4247CK (Exp. 28Nov2019), 4261CK (Exp. 28Nov2019), 4312CK Exp. 28Jun2020) and 4315CK (Exp. 28Jun2020)
Quantity recalled7,505

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0413-2020
FDA event ID
84044
Recalling firm
Randox Laboratories, Crumlin, N/A
Classification
Class II
Status
Terminated
Recall initiated
4 Oct 2019
FDA classified
15 Nov 2019
Reported
27 Nov 2019
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Other Reasons

Timeline

4 Oct 2019Recall initiated by company
15 Nov 2019Classified by FDA+42 days
27 Nov 2019Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Removal of claims for N-proBNP in the Liquid Cardiac Control catalogue number CQ5052 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Product as listed by the FDA

Randox Liquid Cardiac Controls Catalogue Number CQ5052.

Where it was distributed

US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,

CaliforniaColoradoDelawareGeorgiaIndianaMarylandNew JerseyNew YorkPuerto RicoWest Virginia

Questions about this recall

Is Randox Liquid Cardiac Controls recalled?

Yes. Randox Laboratories recalled Randox Liquid Cardiac Controls on 4 Oct 2019. The recall is Class II and its status is Terminated. Recall number Z-0413-2020.

Why was it recalled?

Removal of claims for N-proBNP in the Liquid Cardiac Control catalogue number CQ5052 due to an observed decrease in recovery for N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) in recent lots.

Which lots are affected?

Catalogue Number: CQ5052 GTIN: 05055273207453 Batch/lot: 4244CK (Exp. 28Nov2019), 4247CK (Exp. 28Nov2019), 4261CK (Exp. 28Nov2019), 4312CK Exp. 28Jun2020) and 4315CK (Exp. 28Jun2020)

Where was it sold?

US Distribution: WV, CA, DE, NJ, NY, GA, IN, PR OUS Distribution: CA, PL, CH, JP, NL, IT, CN, GB, IE, RU, MD, BY, SA, VN, AE, BH, DK, CO, ES, FR, TW, PH, TH, OM, HU, IN, KR, ZA, AU, CZ, PE, CL, IR, NZ, BE, DE, BA, SV, SK, HK, PT, PK, BR, TR, UA, SE, QA, LT, PE,

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Randox Laboratories

All 98

Other Other Medical Devices recalls

All 13,778